Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues
Anam Hammid,John K. Fallon,Toni Lassila,Giulia Salluce,Philip C. Smith,Ari Tolonen,Achim Sauer,Arto Urtti,Paavo Honkakoski
DOI: https://doi.org/10.1021/acs.molpharmaceut.0c01154
2021-02-17
Molecular Pharmaceutics
Abstract:Hydrolytic reactions constitute an important pathway of drug metabolism and a significant route of prodrug activation. Many ophthalmic drugs and prodrugs contain ester groups that greatly enhance their permeation across several hydrophobic barriers in the eye before the drugs are either metabolized or released, respectively, via hydrolysis. Thus, the development of ophthalmic drug therapy requires the thorough profiling of substrate specificities, activities, and expression levels of ocular esterases. However, such information is scant in the literature, especially for preclinical species often used in ophthalmology such as rabbits and pigs. Therefore, our aim was to generate systematic information on the activity and expression of carboxylesterases (CESs) and arylacetamide deacetylase (AADAC) in seven ocular tissue homogenates from these two species. The hydrolytic activities were measured using a generic esterase substrate (4-nitrophenyl acetate) and, in the absence of validated substrates for rabbit and pig enzymes, with selective substrates established for human CES1, CES2, and AADAC (d-luciferin methyl ester, fluorescein diacetate, procaine, and phenacetin). Kinetics and inhibition studies were conducted using these substrates and, again due to a lack of validated rabbit and pig CES inhibitors, with known inhibitors for the human enzymes. Protein expression levels were measured using quantitative targeted proteomics. Rabbit ocular tissues showed significant variability in the expression of CES1 (higher in cornea, lower in conjunctiva) and CES2 (higher in conjunctiva, lower in cornea) and a poor correlation of CES expression with hydrolytic activities. In contrast, pig tissues appear to express only CES1, and CES3 and AADAC seem to be either low or absent, respectively, in both species. The current study revealed remarkable species and tissue differences in ocular hydrolytic enzymes that can be taken into account in the design of esterase-dependent prodrugs and drug conjugates, the evaluation of ocular effects of systemic drugs, and in translational and toxicity studies.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c01154.Tables of chromatography gradient program data and MRM parameters for the analysis of CESs and AADAC peptides and figures of Michaelis–Menten kinetics of NPA, DME, and FDA hydrolysis, inhibition of NPA hydrolysis in pig cornea using general and human isoform-selective inhibitors, inhibition of DME hydrolysis by digitonin, inhibition of FDA hydrolysis by human CES2-selective inhibitors, and correlation between hydrolytic activities and CES isozyme contents in pig and rabbit ocular tissues (PDF)This article has not yet been cited by other publications.
pharmacology & pharmacy,medicine, research & experimental